NCEHC Leadership
Toby Schonfeld, PhD: Executive Director (Washington, DC) |
|
![]() |
Dr. Toby Schonfeld joined NCEHC as executive director in March 2020. Prior to this appointment, she directed Prime Review Board, where she was responsible for the oversight, maintenance, and improvement of the Human Research Protection Program. Dr. Schonfeld is a national leader in bioethics, with over 50 national and international presentations and 75 publications. The second edition of her co-edited book (w/D. Micah Hester), Guidance for Healthcare Ethics Committees (Cambridge University Press), was published in 2022. She is a board member of the American Society for Bioethics and Humanities and is a frequent grant reviewer for the US Department of Defense Congressionally Directed Medical Research Program. |
Anita Tarzian, PhD, RN: Deputy Executive Director (Washington, DC) |
|
![]() |
Dr. Anita J. Tarzian joined NCEHC as deputy executive director in June 2020. Prior to this appointment, she was an ethics and research consultant in Baltimore, Maryland and an associate professor at the University of Maryland School of Nursing. She served for over two decades as the program coordinator for the Maryland Healthcare Ethics Committee Network, a regional ethics membership-supported initiative of the University of Maryland School of Law that serves health care ethics committee members. Dr. Tarzian has published and presented widely in the bioethics literature. Creighton University’s Center for Health Policy and Ethics recognized her contributions as a nurse scholar in ethics in their Nursing Legacy project. In 2019, she was elected as a fellow of The Hastings Center, a nonpartisan bioethics research institution founded in 1969. Read more here. |
Raymond S. Frazier, MAE: Director of Operations (Washington, DC) |
|
![]() |
Raymond Frazier joined NCEHC in 2003. As executive officer, he is responsible for the administrative and communications functions of NCEHC. Mr. Frazier has a master’s in applied ethics. His areas of expertise include informed consent and end-of-life issues. |